Riskpilot← Back to searchSign inGet full accessProTreatment Kolding ApS
APSActiveCVR 41476087Idyl 9APhysiotherapy activities · NACE 8695Est. 20207 employeeswww.protreatment.dk
Revenue 2024
DKK 523K
-23% vs 2023
EBITDA margin
8.0%
-80% vs 2023
Equity ratio
-57.8%
Financial strength
Net profit 2024
DKK -440K
-38% vs 2023
| Revenue | DKK 523K | -23% |
| EBITDA | DKK 42K | -80% |
| Net profit | DKK -440K | -38% |
| Total assets | DKK 2,5M | -13% |
| Equity | DKK -1,4M | -44% |
| Employees | 7 | — |
Legal name
ProTreatment Kolding ApS
CVR number
41476087
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
16. juni 2020
Share capital
DKK 40.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller den samlede direktion.
Company purpose
Selskabets formål er at drive fysioterapeutklinik samt enhver virksomhed i hermed stående forbindelse.
Address
Idyl 9A
Phone
+4574643264
Email
tinglev@protreatment.dk
Website
www.protreatment.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 342 | 738 | 415 | 682 | 523 |
| Staff expenses | -292 | -574 | -336 | -471 | -481 |
| EBITDA | 49 | 164 | 79 | 211 | 42 |
| Depreciation & amort. | -133 | -404 | -418 | -425 | -428 |
| EBIT | -84 | -240 | -339 | -214 | -386 |
| Net financials | -45 | -96 | -118 | -195 | -179 |
| Profit before tax | -129 | -336 | -457 | -408 | -564 |
| Tax | -28 | -74 | -100 | -90 | -124 |
| Net profit | -101 | -262 | -356 | -319 | -440 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3.877 | 3.565 | 3.229 | 2.868 | 2.488 |
| Equity | -61 | -323 | -679 | -998 | -1.438 |
| Long-term debt | 3.285 | 3.058 | 3.126 | 3.022 | 2.062 |
| Short-term debt | 635 | 829 | 783 | 844 | 1.864 |
| Total debt | 3.920 | 3.887 | 3.908 | 3.865 | 3.926 |
EBITDA margin
8.0%
This company
15.8%
Market median
-49% vs market
20202024
Equity ratio
-57.8%
This company
38.2%
Market median
-251% vs market
20202024
Return on equity
-44006700.0%
This company
18.4%
Market median
-239166948% vs market
20202024
Net profit margin
-84.2%
This company
8.1%
Market median
-1140% vs market
20202024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20202024
Debt / equity
2.73×
This company
0.62×
Market median
-340% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-06-16 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NS Management | Management | 2020 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ProTreatment Holding ApS | Company | 100.0% | 100.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ProTreatment Holding ApS
ProTreatment Kolding ApS Board members of ProTreatment Kolding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nadia Seistrup | Management | 0 companies |
| Thomas Jørgensen | Chief Executive Officer | 0 companies |